177 related articles for article (PubMed ID: 34611307)
1. Landscape of prognostic signatures and immunogenomics of the AXL/GAS6 axis in renal cell carcinoma.
Hakozaki K; Tanaka N; Takamatsu K; Takahashi R; Yasumizu Y; Mikami S; Shinojima T; Kakimi K; Kamatani T; Miya F; Tsunoda T; Aimono E; Nishihara H; Mizuno R; Oya M
Br J Cancer; 2021 Nov; 125(11):1533-1543. PubMed ID: 34611307
[TBL] [Abstract][Full Text] [Related]
2. Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.
Gustafsson A; Boström AK; Ljungberg B; Axelson H; Dahlbäck B
PLoS One; 2009 Oct; 4(10):e7575. PubMed ID: 19888345
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.
Gustafsson A; Martuszewska D; Johansson M; Ekman C; Hafizi S; Ljungberg B; Dahlbäck B
Clin Cancer Res; 2009 Jul; 15(14):4742-9. PubMed ID: 19567592
[TBL] [Abstract][Full Text] [Related]
4. Gas6-Axl signaling in presence of Sunitinib is enhanced, diversified and sustained in renal tumor cells, resulting in tumor-progressive advantages.
Gustafsson A; Fritz HKM; Dahlbäck B
Exp Cell Res; 2017 Jun; 355(1):47-56. PubMed ID: 28327411
[TBL] [Abstract][Full Text] [Related]
5. S100A10 Is a Critical Mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma.
Xiao Y; Zhao H; Tian L; Nolley R; Diep AN; Ernst A; Fuh KC; Miao YR; von Eyben R; Leppert JT; Brooks JD; Peehl DM; Giaccia AJ; Rankin EB
Cancer Res; 2019 Nov; 79(22):5758-5768. PubMed ID: 31585940
[TBL] [Abstract][Full Text] [Related]
6. Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET.
Rankin EB; Fuh KC; Castellini L; Viswanathan K; Finger EC; Diep AN; LaGory EL; Kariolis MS; Chan A; Lindgren D; Axelson H; Miao YR; Krieg AJ; Giaccia AJ
Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13373-8. PubMed ID: 25187556
[TBL] [Abstract][Full Text] [Related]
7. Tumor tissue and plasma levels of AXL and GAS6 before and after tyrosine kinase inhibitor treatment in EGFR-mutated non-small cell lung cancer.
Nonagase Y; Takeda M; Azuma K; Hayashi H; Haratani K; Tanaka K; Yonesaka K; Ishii H; Hoshino T; Nakagawa K
Thorac Cancer; 2019 Oct; 10(10):1928-1935. PubMed ID: 31419057
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Increased Expression of the Axl/Gas6 Signal Cascade and Prognosis of Patients with Upper Tract Urothelial Carcinoma.
Hattori S; Kikuchi E; Kosaka T; Miyazaki Y; Tanaka N; Miyajima A; Mikami S; Oya M
Ann Surg Oncol; 2016 Feb; 23(2):663-70. PubMed ID: 26350366
[TBL] [Abstract][Full Text] [Related]
9. Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients.
Ishikawa M; Sonobe M; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Date H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S467-76. PubMed ID: 23242819
[TBL] [Abstract][Full Text] [Related]
10. An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis.
Kariolis MS; Miao YR; Jones DS; Kapur S; Mathews II; Giaccia AJ; Cochran JR
Nat Chem Biol; 2014 Nov; 10(11):977-83. PubMed ID: 25242553
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer.
Tanaka M; Siemann DW
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576116
[TBL] [Abstract][Full Text] [Related]
12. Gas6 expression and Tyrosine kinase Axl Sky receptors: Their relation with tumor stage and grade in patients with bladder cancer.
Akgül M; Baykan Ö; Çağman Z; Özyürek M; Tinay İ; Akbal C; Uras F; Türkeri L
Arch Ital Urol Androl; 2021 Jun; 93(2):148-152. PubMed ID: 34286546
[TBL] [Abstract][Full Text] [Related]
13. AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases.
Wu X; Ma W; Zhou Q; Yan H; Lim ZF; Huang M; Deng C; Yu X; Su H; Komo S; Yang H; Zhang X; Wen S; Zhang Z; Ma PC
J Cancer Res Clin Oncol; 2017 Oct; 143(10):1947-1957. PubMed ID: 28551766
[TBL] [Abstract][Full Text] [Related]
14. The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion.
Zdżalik-Bielecka D; Poświata A; Kozik K; Jastrzębski K; Schink KO; Brewińska-Olchowik M; Piwocka K; Stenmark H; Miączyńska M
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244439
[TBL] [Abstract][Full Text] [Related]
15. Gas6 attenuates lipopolysaccharide‑induced TNF‑α expression and apoptosis in H9C2 cells through NF‑κB and MAPK inhibition via the Axl/PI3K/Akt pathway.
Li M; Ye J; Zhao G; Hong G; Hu X; Cao K; Wu Y; Lu Z
Int J Mol Med; 2019 Sep; 44(3):982-994. PubMed ID: 31524235
[TBL] [Abstract][Full Text] [Related]
16. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
[TBL] [Abstract][Full Text] [Related]
17. Corosolic Acid Attenuates the Invasiveness of Glioblastoma Cells by Promoting CHIP-Mediated AXL Degradation and Inhibiting GAS6/AXL/JAK Axis.
Sun LW; Kao SH; Yang SF; Jhang SW; Lin YC; Chen CM; Hsieh YH
Cells; 2021 Oct; 10(11):. PubMed ID: 34831142
[TBL] [Abstract][Full Text] [Related]
18. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
[TBL] [Abstract][Full Text] [Related]
19. Gas6/Axl signaling attenuates alveolar inflammation in ischemia-reperfusion-induced acute lung injury by up-regulating SOCS3-mediated pathway.
Peng CK; Wu CP; Lin JY; Peng SC; Lee CH; Huang KL; Shen CH
PLoS One; 2019; 14(7):e0219788. PubMed ID: 31318922
[TBL] [Abstract][Full Text] [Related]
20. Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases.
Fiebeler A; Park JK; Muller DN; Lindschau C; Mengel M; Merkel S; Banas B; Luft FC; Haller H
Am J Kidney Dis; 2004 Feb; 43(2):286-95. PubMed ID: 14750094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
